Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 3;12(5):e059563.
doi: 10.1136/bmjopen-2021-059563.

Protocol for a type 2 hybrid effectiveness-implementation study expanding, implementing and evaluating electronic health record-integrated patient-reported symptom monitoring in a multisite cancer centre

Sofia F Garcia  1 , Justin D Smith  2   3 , Michael Kallen  4 , Kimberly A Webster  4 , Madison Lyleroehr  4 , Sheetal Kircher  3 , Michael Bass  4 , David Cella  4 , Frank J Penedo  5
Affiliations

Protocol for a type 2 hybrid effectiveness-implementation study expanding, implementing and evaluating electronic health record-integrated patient-reported symptom monitoring in a multisite cancer centre

Sofia F Garcia et al. BMJ Open. .

Abstract

Introduction: Cancer symptom monitoring and management interventions can address concerns that may otherwise go undertreated. However, such programmes and their evaluations remain largely limited to trials versus healthcare systemwide applications. We previously developed and piloted an electronic patient-reported symptom and need assessment ('cPRO' for cancer patient-reported outcomes) within the electronic health record (EHR). This study will expand cPRO implementation to medical oncology clinics across a large healthcare system. We will conduct a formal evaluation via a stepped wedge trial with a type 2 hybrid effectiveness-implementation design.

Methods and analysis: Aim 1 comprises a mixed method evaluation of cPRO implementation. Adult outpatients will complete cPRO assessments (pain, fatigue, physical function, depression, anxiety and supportive care needs) before medical oncology visits. Results are available in the EHR; severe symptoms and endorsed needs trigger clinician notifications. We will track implementation strategies using the Longitudinal Implementation Strategy Tracking System. Aim 2 will evaluate cPRO's impact on patient and system outcomes over 12 months via (a) a quality improvement study (n=4000 cases) and (b) a human subjects substudy (n=1000 patients). Aim 2a will evaluate EHR-documented healthcare usage and patient satisfaction. In aim 2b, participating patients will complete patient-reported healthcare utilisation and quality, symptoms and health-related quality of life measures at baseline, 6 and 12 months. We will analyse data using generalised linear mixed models and estimate individual trajectories of patient-reported symptom scores at baseline, 6 and 12 months. Using growth mixture modelling, we will characterise the overall trajectories of each symptom. Aim 3 will identify cPRO implementation facilitators and barriers via mixed methods research gathering feedback from stakeholders. Patients (n=50) will participate in focus groups or interviews. Clinicians and administrators (n=40) will complete surveys to evaluate implementation. We will graphically depict longitudinal implementation survey results and code qualitative data using directed content analysis.

Ethics and dissemination: This study was approved by the Northwestern University Institutional Review Board (STU00207807). Findings will be disseminated via local and conference presentations and peer-reviewed journals.

Trial registration number: NCT04014751; ClinicalTrials.gov.

Keywords: information technology; mental health; oncology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
EHR-integrated symptom and needs assessment (cPRO) system. cPRO, cancer patient-reported outcomes; EHR, Electronic health-record.
Figure 2
Figure 2
A 4 year, type 2 hybrid effectiveness-implementation design to test the expansion and implementation of cPRO across oncology care practices in a large healthcare system. cPRO, cancer patient-reported outcomes.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Miller KD, Nogueira L, Mariotto AB, et al. . Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin 2019;69:363–85. 10.3322/caac.21565 - DOI - PubMed
    1. Caruso R, Nanni MG, Riba MB, et al. . The burden of psychosocial morbidity related to cancer: patient and family issues. Int Rev Psychiatry 2017;29:389–402. 10.1080/09540261.2017.1288090 - DOI - PubMed
    1. Penedo FJ, Cella D. Responding to the quality imperative to embed mental health care into ambulatory oncology. Cancer 2017;123:382–6. 10.1002/cncr.30402 - DOI - PMC - PubMed
    1. Mehnert A, Brähler E, Faller H, et al. . Four-week prevalence of mental disorders in patients with cancer across major tumor entities. J Clin Oncol 2014;32:3540–6. 10.1200/JCO.2014.56.0086 - DOI - PubMed
    1. Kanani R, Davies EA, Hanchett N, et al. . The association of mood disorders with breast cancer survival: an investigation of linked cancer registration and hospital admission data for South East England. Psychooncology 2016;25:19–27. 10.1002/pon.4037 - DOI - PMC - PubMed

Publication types

Associated data

LinkOut - more resources